# Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy

> **NCT07204132** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **PROCEDURE:** TURBT combined with cryoablation-assisted postoperative immunotherapy
- **PROCEDURE:** The conventional surgery treatment group

## Key facts

- **NCT ID:** NCT07204132
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07204132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07204132, "Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07204132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*